Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus

Masayuki Amagai, T. Hashimoto, K. J. Green, N. Shimizu, T. Nishikawa

Research output: Contribution to journalArticle

221 Citations (Scopus)

Abstract

Patients with the autoimmune blistering disease pemphigus foliaceus (PF) have circulating autoantibodies directed against the desmosomal cadherin desmoglein 1 (Dsg1). Based on the fact that purified IgG fractions from PF patients induce loss of cell adhesion in organ culture and in a neonatal mouse model, it has been proposed that these anti-Dsg1 antibodies play a pathogenic role in blister formation. To directly address whether antibodies in PF sera specific for the Dsg1 extracellular domain are indeed pathogenic in the disease, PFIg, a chimeric protein containing the entire extracellular domain of human Dsg1 and the constant region of human IgG1, was produced by baculovirus expression. Incubation of PF patients' sera with the PFIg baculoprotein removed the immunoreactivity of autoantibodies against keratinocyte cell surfaces in all 20 PF and eight Brazilian PF patients' sera tested. This adsorption was conformation dependent, because PFIg protein denatured by low pH or heat was no longer able to adsorb the immunoreactivity of PF sera. Furthermore, the incubation with the PFIg baculoprotein eliminated the pathogenic activity of PF patients' sera and prevented gross blister formation in a neonatal mouse model of pemphigus. Anti-Dsg1 antibodies eluted from the PFIg protein column were pathogenic as they resulted in the appearance of gross blisters in neonatal mice with typical histologic findings of PF. These observations indicate that the extracellular domain of Dsg1 expressed by baculovirus is capable of specifically immunoadsorbing pathogenic autoantibodies from PF patients' sera and provide direct evidence that the anti-Dsg1 autoantibodies in PF sera are indeed pathogenic. The availability of this Dsg1 recombinant protein may facilitate the development of antigen-specific plasmapheresis as a novel therapeutic strategy in pemphigus.

Original languageEnglish
Pages (from-to)895-901
Number of pages7
JournalJournal of Investigative Dermatology
Volume104
Issue number6
Publication statusPublished - 1995
Externally publishedYes

Fingerprint

Desmoglein 1
Pemphigus
Autoantibodies
Antigens
Serum
Blister
Antibodies
Desmosomal Cadherins
Immunoglobulin G
Baculoviridae
Proteins
Cell adhesion
Cell culture
Recombinant Proteins
Conformations
Plasmapheresis
Organ Culture Techniques
Availability
Cadherins
Keratinocytes

Keywords

  • autoimmune disease
  • baculovirus expression
  • cadherin
  • desmoglein

ASJC Scopus subject areas

  • Dermatology

Cite this

Amagai, M., Hashimoto, T., Green, K. J., Shimizu, N., & Nishikawa, T. (1995). Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. Journal of Investigative Dermatology, 104(6), 895-901.

Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. / Amagai, Masayuki; Hashimoto, T.; Green, K. J.; Shimizu, N.; Nishikawa, T.

In: Journal of Investigative Dermatology, Vol. 104, No. 6, 1995, p. 895-901.

Research output: Contribution to journalArticle

Amagai, M, Hashimoto, T, Green, KJ, Shimizu, N & Nishikawa, T 1995, 'Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus', Journal of Investigative Dermatology, vol. 104, no. 6, pp. 895-901.
Amagai, Masayuki ; Hashimoto, T. ; Green, K. J. ; Shimizu, N. ; Nishikawa, T. / Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus. In: Journal of Investigative Dermatology. 1995 ; Vol. 104, No. 6. pp. 895-901.
@article{54cac20666354cfe951e2f89fe731365,
title = "Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus",
abstract = "Patients with the autoimmune blistering disease pemphigus foliaceus (PF) have circulating autoantibodies directed against the desmosomal cadherin desmoglein 1 (Dsg1). Based on the fact that purified IgG fractions from PF patients induce loss of cell adhesion in organ culture and in a neonatal mouse model, it has been proposed that these anti-Dsg1 antibodies play a pathogenic role in blister formation. To directly address whether antibodies in PF sera specific for the Dsg1 extracellular domain are indeed pathogenic in the disease, PFIg, a chimeric protein containing the entire extracellular domain of human Dsg1 and the constant region of human IgG1, was produced by baculovirus expression. Incubation of PF patients' sera with the PFIg baculoprotein removed the immunoreactivity of autoantibodies against keratinocyte cell surfaces in all 20 PF and eight Brazilian PF patients' sera tested. This adsorption was conformation dependent, because PFIg protein denatured by low pH or heat was no longer able to adsorb the immunoreactivity of PF sera. Furthermore, the incubation with the PFIg baculoprotein eliminated the pathogenic activity of PF patients' sera and prevented gross blister formation in a neonatal mouse model of pemphigus. Anti-Dsg1 antibodies eluted from the PFIg protein column were pathogenic as they resulted in the appearance of gross blisters in neonatal mice with typical histologic findings of PF. These observations indicate that the extracellular domain of Dsg1 expressed by baculovirus is capable of specifically immunoadsorbing pathogenic autoantibodies from PF patients' sera and provide direct evidence that the anti-Dsg1 autoantibodies in PF sera are indeed pathogenic. The availability of this Dsg1 recombinant protein may facilitate the development of antigen-specific plasmapheresis as a novel therapeutic strategy in pemphigus.",
keywords = "autoimmune disease, baculovirus expression, cadherin, desmoglein",
author = "Masayuki Amagai and T. Hashimoto and Green, {K. J.} and N. Shimizu and T. Nishikawa",
year = "1995",
language = "English",
volume = "104",
pages = "895--901",
journal = "Journal of Investigative Dermatology",
issn = "0022-202X",
publisher = "Nature Publishing Group",
number = "6",

}

TY - JOUR

T1 - Antigen-specific immunoadsorption of pathogenic autoantibodies in pemphigus foliaceus

AU - Amagai, Masayuki

AU - Hashimoto, T.

AU - Green, K. J.

AU - Shimizu, N.

AU - Nishikawa, T.

PY - 1995

Y1 - 1995

N2 - Patients with the autoimmune blistering disease pemphigus foliaceus (PF) have circulating autoantibodies directed against the desmosomal cadherin desmoglein 1 (Dsg1). Based on the fact that purified IgG fractions from PF patients induce loss of cell adhesion in organ culture and in a neonatal mouse model, it has been proposed that these anti-Dsg1 antibodies play a pathogenic role in blister formation. To directly address whether antibodies in PF sera specific for the Dsg1 extracellular domain are indeed pathogenic in the disease, PFIg, a chimeric protein containing the entire extracellular domain of human Dsg1 and the constant region of human IgG1, was produced by baculovirus expression. Incubation of PF patients' sera with the PFIg baculoprotein removed the immunoreactivity of autoantibodies against keratinocyte cell surfaces in all 20 PF and eight Brazilian PF patients' sera tested. This adsorption was conformation dependent, because PFIg protein denatured by low pH or heat was no longer able to adsorb the immunoreactivity of PF sera. Furthermore, the incubation with the PFIg baculoprotein eliminated the pathogenic activity of PF patients' sera and prevented gross blister formation in a neonatal mouse model of pemphigus. Anti-Dsg1 antibodies eluted from the PFIg protein column were pathogenic as they resulted in the appearance of gross blisters in neonatal mice with typical histologic findings of PF. These observations indicate that the extracellular domain of Dsg1 expressed by baculovirus is capable of specifically immunoadsorbing pathogenic autoantibodies from PF patients' sera and provide direct evidence that the anti-Dsg1 autoantibodies in PF sera are indeed pathogenic. The availability of this Dsg1 recombinant protein may facilitate the development of antigen-specific plasmapheresis as a novel therapeutic strategy in pemphigus.

AB - Patients with the autoimmune blistering disease pemphigus foliaceus (PF) have circulating autoantibodies directed against the desmosomal cadherin desmoglein 1 (Dsg1). Based on the fact that purified IgG fractions from PF patients induce loss of cell adhesion in organ culture and in a neonatal mouse model, it has been proposed that these anti-Dsg1 antibodies play a pathogenic role in blister formation. To directly address whether antibodies in PF sera specific for the Dsg1 extracellular domain are indeed pathogenic in the disease, PFIg, a chimeric protein containing the entire extracellular domain of human Dsg1 and the constant region of human IgG1, was produced by baculovirus expression. Incubation of PF patients' sera with the PFIg baculoprotein removed the immunoreactivity of autoantibodies against keratinocyte cell surfaces in all 20 PF and eight Brazilian PF patients' sera tested. This adsorption was conformation dependent, because PFIg protein denatured by low pH or heat was no longer able to adsorb the immunoreactivity of PF sera. Furthermore, the incubation with the PFIg baculoprotein eliminated the pathogenic activity of PF patients' sera and prevented gross blister formation in a neonatal mouse model of pemphigus. Anti-Dsg1 antibodies eluted from the PFIg protein column were pathogenic as they resulted in the appearance of gross blisters in neonatal mice with typical histologic findings of PF. These observations indicate that the extracellular domain of Dsg1 expressed by baculovirus is capable of specifically immunoadsorbing pathogenic autoantibodies from PF patients' sera and provide direct evidence that the anti-Dsg1 autoantibodies in PF sera are indeed pathogenic. The availability of this Dsg1 recombinant protein may facilitate the development of antigen-specific plasmapheresis as a novel therapeutic strategy in pemphigus.

KW - autoimmune disease

KW - baculovirus expression

KW - cadherin

KW - desmoglein

UR - http://www.scopus.com/inward/record.url?scp=0029044631&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029044631&partnerID=8YFLogxK

M3 - Article

VL - 104

SP - 895

EP - 901

JO - Journal of Investigative Dermatology

JF - Journal of Investigative Dermatology

SN - 0022-202X

IS - 6

ER -